The feasibility of home monitoring of young people with cystic fibrosis: Results from CLIMB-CF
Edmondson, C., Westrupp, N., Seddon, P., Olden, C., Wallis, C., Dawson, C., Brodlie, M., Baxter, F., McCormick, J., MacFarlane, S., Rice, D., Macleod, A., Brooker, R., Connon, M., Ghayyda, S., Blaikie, L., Thursfield, R., Brown, L., Price, A., Fleischer, E., Itterman, J., Hughes, D., Barrett, P., Surette, M., Donnelly, C., Mateos-Corral, D., Padley, G., Wallenburg, J., Brownlee, K., Alton, E.W.F.W., Bush, A., Davies, J.C.
Published in Journal of cystic fibrosis (01.01.2022)
Published in Journal of cystic fibrosis (01.01.2022)
Get full text
Journal Article
P67 Moving into year 7: A pilot study to assess to the usefulness of an on-line group session to prepare young people with cystic fibrosis for transitioning to secondary school
Beech, G, Lawrence, C, Walsh, A, Fogg, H, Woodland, C, Thursfield, RM
Published in Thorax (11.11.2022)
Published in Thorax (11.11.2022)
Get full text
Journal Article
WS16.2 The prevalence of gastroesophageal reflux disease in infants with cystic fibrosis diagnosed by newborn screening and the relationship with lung infection
Thursfield, R, Ravindran, R, Bush, A, Davies, J.C, Carr, S.B
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
452 Does gamification improve the experience of airway clearance for children with cystic fibrosis: A randomized controlled feasibility trial of a mobile device
Walsh, A., Davies, S., Jackson, W., Bouliotis, G., Thursfield, R.
Published in Journal of cystic fibrosis (01.10.2023)
Published in Journal of cystic fibrosis (01.10.2023)
Get full text
Journal Article
29 Hypoxic challenge testing and its role in paediatric cardiology
Khodaghalian, B, Jones, CB, Laurence, P, Thursfield, R
Published in Heart (British Cardiac Society) (01.02.2018)
Published in Heart (British Cardiac Society) (01.02.2018)
Get full text
Journal Article
P171 Spirometry quality improvement exercise across a paediatric cystic fibrosis network
Lawrence, P., Mayell, S., Southern, K., Thursfield, R.
Published in Journal of cystic fibrosis (01.06.2020)
Published in Journal of cystic fibrosis (01.06.2020)
Get full text
Journal Article
P107 Real-world impact of ELX/TEZ/IVA on quality of life of children with CF aged 6–11 years and primary caregivers in the UK: MAGNIFY, a prospective, observational, non interventional study
Thia, LP, Thursfield, R, Lee, T, Legg, J, Maitra, A, Urquhart, DS, McKinnon, C, Lu, M, Liu, J, Jennings, M, Vega-Hernandez, G
Published in Thorax (06.11.2023)
Published in Thorax (06.11.2023)
Get full text
Journal Article
137 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 96-week results from an open-label extension study
Goralski, J., Daines, C., Pittman, J., Rayment, J., Robinson, P., Thursfield, R., Stehling, F., Ratjen, F., Ahluwalia, N., Chu, C., Scirica, C., Weinstock, T., Mall, M.
Published in Journal of cystic fibrosis (01.09.2024)
Published in Journal of cystic fibrosis (01.09.2024)
Get full text
Journal Article
P387 Strengths and difficulties scores in children with cystic fibrosis enrolled in the CLIMB-CF study
Edmondson, C., Westrupp, N., Seddon, P., Wallis, C., Brodlie, M., McCormick, J., Thursfield, R., Price, A., Hughes, D., Wallenburg, J., Brownlee, K., Alton, E.W., Bush, A., Davies, J.C.
Published in Journal of cystic fibrosis (01.06.2024)
Published in Journal of cystic fibrosis (01.06.2024)
Get full text
Journal Article
137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study
Goralski, J., Daines, C., Pittman, J., Rayment, J., Robinson, P., Thursfield, R., Stehling, F., Ratjen, F., Ahluwalia, N., Chu, C., Menon, P., Weinstock, T., Mall, M.
Published in Journal of cystic fibrosis (01.10.2023)
Published in Journal of cystic fibrosis (01.10.2023)
Get full text
Journal Article
P118 Real-world impact of elexacaftor/tezacaftor/ivacaftor on quality of life of children with cystic fibrosis aged 6–11 years and primary caregivers in the UK: MAGNIFY, a prospective, observational, non-interventional study
Thia, L.P., Thursfield, R., Lee, T., Legg, J., Maitra, A., Urquhart, D.S., McKinnon, C., Lu, M., Liu, J., Jennings, M., Vega-Hernandez, G.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
P228 Multicentre reviewof lung microbiome for patients with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
Rajkumar, D., Hitmarova, S., Dunne, T., King, C., Ping, D., Ramachandran, S., Redfern, S., Parry, S., Gleig, H., Wen, L., Lacy, D., Jayaram, R., Southward, S., Kandasamy, S., Chilukuri, L., Prasad, A., Anderson, R., Richards, L., Thursfield, R.
Published in Journal of cystic fibrosis (01.06.2024)
Published in Journal of cystic fibrosis (01.06.2024)
Get full text
Journal Article